错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

miR-184 represses β-catenin and behaves as a skin tumor suppressor

  • Lubov Turovsky,
  • Ghazal Kheshaiboun,
  • Gharam Yassen,
  • Sara Nagosa,
  • Ilanit Boyango,
  • Aya Amitai-Lange,
  • Swarnabh Bhattacharya,
  • Neta Ilan,
  • Israel Vlodavsky,
  • Daniel Aberdam,
  • Ruby Shalom-Feuerstein,
  • Emily Avitan-Hersh

摘要

miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement, repression of miR-184 in human squamous cell carcinoma (SCC) enhances neoplastic hallmarks of human SCC cells in vitro and tumor development in vivo. Characterization of miR-184-regulatory network, suggests that miR-184 inhibits pro-oncogenic pathways, cell proliferation, and epithelial to mesenchymal transformation. Of note, depletion of miR-184 enhances the levels of β-catenin under homeostasis and following experimental skin carcinogenesis. Finally, the repression of β-catenin by miR-184, inhibits the neoplastic phenotype of SCC cells. Taken together, miR-184 behaves as an epidermal tumor suppressor, and may provide a potentially useful target for skin SCC therapy.